Sandbox:Hannan: Difference between revisions
Jump to navigation
Jump to search
Hannan Javed (talk | contribs) No edit summary |
Hannan Javed (talk | contribs) No edit summary |
||
Line 40: | Line 40: | ||
* MDS, unclassifiable | * MDS, unclassifiable | ||
* Provisional entity: Refractory cytopenia of childhood | * Provisional entity: Refractory cytopenia of childhood | ||
* Myeloid neoplasms with germ line predisposition | |||
| | |||
| | |||
| | |||
|- | |||
|Acute myeloid leukemia (AML) and related neoplasms | |||
* AML with recurrent genetic abnormalities | |||
# AML with t(8;21)(q22;q22.1);RUNX1-RUNX1T1 | |||
# AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22);CBFB-MYH11 | |||
# APL with PML-RARA | |||
# AML with t(9;11)(p21.3;q23.3);MLLT3-KMT2A | |||
# AML with t(6;9)(p23;q34.1);DEK-NUP214 | |||
# AML with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM | |||
# AML (megakaryoblastic) with t(1;22)(p13.3;q13.3);RBM15-MKL1 | |||
# Provisional entity: AML with BCR-ABL1 | |||
# AML with mutated NPM1 | |||
# AML with biallelic mutations of CEBPA | |||
# Provisional entity: AML with mutated RUNX1 | |||
AML with myelodysplasia-related changes | |||
Therapy-related myeloid neoplasms | |||
AML, NOS | |||
AML with minimal differentiation | |||
AML without maturation | |||
AML with maturation | |||
Acute myelomonocytic leukemia | |||
Acute monoblastic/monocytic leukemia | |||
Pure erythroid leukemia | |||
Acute megakaryoblastic leukemia | |||
Acute basophilic leukemia | |||
Acute panmyelosis with myelofibrosis | |||
Myeloid sarcoma | |||
Myeloid proliferations related to Down syndrome | |||
Transient abnormal myelopoiesis (TAM) | |||
Myeloid leukemia associated with Down syndrome | |||
| | |||
| | |||
| | |||
|- | |||
| | |||
| | |||
| | |||
| | |||
|- | |||
| | |||
| | | | ||
| | | |
Revision as of 12:30, 15 January 2019
Other myeloid neoplasm and acute leukemia | |||
---|---|---|---|
Myeloid/lymphoid neoplasms with eosinophilia and rearrangement of
PDGFRA, PDGFRB, or FGFR1, or with PCM1-JAK2
|
|||
Myelodysplastic/myeloproliferative neoplasms (MDS/MPN)
|
|||
Myelodysplastic syndromes (MDS)
|
|||
Acute myeloid leukemia (AML) and related neoplasms
AML with myelodysplasia-related changes Therapy-related myeloid neoplasms AML, NOS AML with minimal differentiation AML without maturation AML with maturation Acute myelomonocytic leukemia Acute monoblastic/monocytic leukemia Pure erythroid leukemia Acute megakaryoblastic leukemia Acute basophilic leukemia Acute panmyelosis with myelofibrosis Myeloid sarcoma Myeloid proliferations related to Down syndrome Transient abnormal myelopoiesis (TAM) Myeloid leukemia associated with Down syndrome |
|||
(CML), BCR-ABL1+
- prefibrotic/early stage
- overt fibrotic stage